Dr. Mark Edward Polhemus, MD

Dr. Polhemus practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Polhemus' NPI, 1891027512, was assigned on February 5, 2010. Dr. Polhemus holds New Mexico license MD2022-1151.

Dr. Polhemus' primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Polhemus' primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Polhemus to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Polhemus practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Polhemus' primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Polhemus' licenses on file in 2 states: New Mexico and New York.

CMS data shows 129 Medicare services from Dr. Polhemus across 5 procedure codes in 2024, for 85 Medicare patients. Medicare paid $11,635 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 85 Medicare patients who saw Dr. Polhemus in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 58% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Polhemus' median patient age at 68, with 40% women.

In 2024, Dr. Polhemus wrote 282 Medicare Part D claims for 83 patients. 97% of them were for generic drugs. CMS names the drug for 170 of them, across 8 drugs with 11 or more claims each, at $10,330 in total drug cost. In 2023, CMS named 322 claims across 13 drugs.

Dr. Polhemus accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 32 papers to Dr. Polhemus, published from 2011 to 2023. 2013 was the busiest year, with 4. The most frequent topics are Dengue, Malaria Vaccines and Ecuador. Dr. Polhemus has published most often in Am J Trop Med Hyg. Dr. Polhemus' most frequent co-authors are Christian Fischer Ockenhouse, MD, Michele Donna Spring, MD and Douglas Walsh, MD.

Dmand AI links Dr. Polhemus to 2 clinical trials. Conditions studied include Dengue, Rabies and Flavivirus Infections.

CMS Open Payments shows 15 general payments to Dr. Polhemus from 5 drug and device companies from 2016 to 2023. Travel and lodging make up the largest share, 51% of the total. Sanofi Pasteur Inc. paid the most, $605.